150 related articles for article (PubMed ID: 12161090)
1. Design of the Wegener's Granulomatosis Etanercept Trial (WGET).
WGET Research Group
Control Clin Trials; 2002 Aug; 23(4):450-68. PubMed ID: 12161090
[TBL] [Abstract][Full Text] [Related]
2. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).
Tomasson G; Boers M; Walsh M; LaValley M; Cuthbertson D; Carette S; Davis JC; Hoffman GS; Khalidi NA; Langford CA; McAlear CA; McCune WJ; Monach PA; Seo P; Specks U; Spiera R; St Clair EW; Stone JH; Ytterberg SR; Merkel PA
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):273-9. PubMed ID: 21954229
[TBL] [Abstract][Full Text] [Related]
3. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
4. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
5. Solid malignancies among etanercept-treated patients with granulomatosis with polyangiitis (Wegener's): long-term followup of a multicenter longitudinal cohort.
Silva F; Seo P; Schroeder DR; Stone JH; Merkel PA; Hoffman GS; Spiera R; Sebastian JK; Davis JC; St Clair EW; Allen NB; McCune WJ; Ytterberg SR; Specks U;
Arthritis Rheum; 2011 Aug; 63(8):2495-503. PubMed ID: 21484770
[TBL] [Abstract][Full Text] [Related]
6. Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
Stone JH; Holbrook JT; Marriott MA; Tibbs AK; Sejismundo LP; Min YI; Specks U; Merkel PA; Spiera R; Davis JC; St Clair EW; McCune WJ; Ytterberg SR; Allen NB; Hoffman GS;
Arthritis Rheum; 2006 May; 54(5):1608-18. PubMed ID: 16646004
[TBL] [Abstract][Full Text] [Related]
7. Advances in the therapy of Wegener's granulomatosis.
Hellmich B; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
[TBL] [Abstract][Full Text] [Related]
8. Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.
Stone JH;
Arthritis Rheum; 2003 Aug; 48(8):2299-309. PubMed ID: 12905485
[TBL] [Abstract][Full Text] [Related]
9. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological therapy for Wegener's granulomatosis.
White ES; Lynch JP
Drugs; 2006; 66(9):1209-28. PubMed ID: 16827598
[TBL] [Abstract][Full Text] [Related]
11. Brief report: The value of a patient global assessment of disease activity in granulomatosis with polyangiitis (Wegener's).
Tomasson G; Davis JC; Hoffman GS; McCune WJ; Specks U; Spiera R; St Clair EW; Stone JH; Merkel PA
Arthritis Rheumatol; 2014 Feb; 66(2):428-32. PubMed ID: 24504815
[TBL] [Abstract][Full Text] [Related]
12. TNF-α blocker therapy and solid malignancy risk in ANCA-associated vasculitis.
Silva F; Cisternas M; Specks U
Curr Rheumatol Rep; 2012 Dec; 14(6):501-8. PubMed ID: 22956157
[TBL] [Abstract][Full Text] [Related]
13. Ovarian reserve diminished by oral cyclophosphamide therapy for granulomatosis with polyangiitis (Wegener's).
Clowse ME; Copland SC; Hsieh TC; Chow SC; Hoffman GS; Merkel PA; Spiera RF; Davis JC; McCune WJ; Ytterberg SR; St Clair EW; Allen NB; Specks U; Stone JH;
Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1777-81. PubMed ID: 22127969
[TBL] [Abstract][Full Text] [Related]
14. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.
Dougados M; Wood E; Combe B; Schaeverbeke T; Miceli-Richard C; Berenbaum F; Koppiker N; Dubanchet A; Logeart I
Arthritis Res Ther; 2014 Nov; 16(6):481. PubMed ID: 25428762
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies.
Goek ON; Stone JH
Curr Opin Rheumatol; 2005 May; 17(3):257-64. PubMed ID: 15838233
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial.
Bachelez H; van de Kerkhof PC; Strohal R; Kubanov A; Valenzuela F; Lee JH; Yakusevich V; Chimenti S; Papacharalambous J; Proulx J; Gupta P; Tan H; Tawadrous M; Valdez H; Wolk R;
Lancet; 2015 Aug; 386(9993):552-61. PubMed ID: 26051365
[TBL] [Abstract][Full Text] [Related]
18. [Anti-TNF alpha agents in vasculitis].
Solans Laqué R; Bosch Gil JA
Med Clin (Barc); 2008 Feb; 130(3):93-4. PubMed ID: 18261379
[No Abstract] [Full Text] [Related]
19. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
Moreland LW; Schiff MH; Baumgartner SW; Tindall EA; Fleischmann RM; Bulpitt KJ; Weaver AL; Keystone EC; Furst DE; Mease PJ; Ruderman EM; Horwitz DA; Arkfeld DG; Garrison L; Burge DJ; Blosch CM; Lange ML; McDonnell ND; Weinblatt ME
Ann Intern Med; 1999 Mar; 130(6):478-86. PubMed ID: 10075615
[TBL] [Abstract][Full Text] [Related]
20. Etanercept for idiopathic pulmonary fibrosis: lessons on clinical trial design.
Jackson RM; Fell CD
Am J Respir Crit Care Med; 2008 Nov; 178(9):889-91. PubMed ID: 18945868
[No Abstract] [Full Text] [Related]
[Next] [New Search]
